Literature DB >> 25743328

Distant Metastases in Patients with Carcinoma of the Major Salivary Glands.

Safina Ali1, Robert Bryant1, Frank L Palmer1, Monica DiLorenzo1, Jatin P Shah1, Snehal G Patel1, Ian Ganly2.   

Abstract

BACKGROUND: This study aimed to show the incidence of distant metastases (DM) in salivary gland cancer as well as the types of histology most commonly associated with it and to identify factors predictive of DM.
METHODS: The study identified 301 patients who underwent surgery for cancer of the major salivary glands at Memorial Sloan-Kettering Cancer center between 1985 and 2009. Clinical, tumor, and treatment characteristics were recorded. Tumors were categorized as low-, intermediate-, and high-risk pathology based on histologic subtype and grade. Factors predictive of distant recurrence-free probability (DRFP) were determined by uni- and multivariable analyses.
RESULTS: The primary tumor was parotid in 266 patients (88 %), and 96 tumors (32 %) were clinical T3/T4. For 57 patients (18.9 %), DM developed with a 5-year DRFP of 72.7 %. The most common site of metastasis was the lung (50 %). The clinical predictors were male gender, cT4 stage, cN+ stage, and clinical overall stage. The multivariable analysis of clinical variables showed male gender (p = 0.018), cT4 stage (p < 0.001), and cN+ stage (p = 0.004) to be significant. The pathologic predictors were high-risk and high-grade pathology, vascular invasion, perineural invasion, positive margins, pT4 stage, pN+ stage, and overall stage. The multivariable analysis of pathologic variables showed high-grade pathology (p < 0.001), perineural invasion (p = 0.005), and pN+ stage (p = 0.002) to be significant.
CONCLUSIONS: Distant metastases developed in approximately 20 % of the patients with salivary gland cancer. The most common site of metastases was the lung. The significant predictors of DM were cT4, cN+, male gender, high-grade pathology, perineural invasion, and positive nodal disease.

Entities:  

Mesh:

Year:  2015        PMID: 25743328      PMCID: PMC4976494          DOI: 10.1245/s10434-015-4454-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

Review 1.  Distant metastases from salivary glands cancer.

Authors:  P J Bradley
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2001 Jul-Aug       Impact factor: 1.538

2.  Adenoid cystic carcinoma of the head and neck.

Authors:  A S Jones; J W Hamilton; H Rowley; D Husband; T R Helliwell
Journal:  Clin Otolaryngol Allied Sci       Date:  1997-10

3.  Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.

Authors:  Michael Jaehne; Kerstin Roeser; Thorsten Jaekel; Jan David Schepers; Natalie Albert; Thomas Löning
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

4.  Failure patterns and factors affecting prognosis of salivary gland carcinoma: retrospective study.

Authors:  P M Teo; A T Chan; W Y Lee; S F Leung; E S Chan; C O Mok
Journal:  Hong Kong Med J       Date:  2000-03       Impact factor: 2.227

5.  High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.

Authors:  Ronghui Xia; Rongrui Zhou; Zhen Tian; Chunye Zhang; Lizhen Wang; Yuhua Hu; Jing Han; Jiang Li
Journal:  Arch Pathol Lab Med       Date:  2013-12       Impact factor: 5.534

Review 6.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

Review 7.  Prognostic factors in malignant tumours of the salivary glands.

Authors:  Paul M Speight; A William Barrett
Journal:  Br J Oral Maxillofac Surg       Date:  2009-05-05       Impact factor: 1.651

8.  TNM: evolution and relation to other prognostic factors.

Authors:  Leslie H Sobin
Journal:  Semin Surg Oncol       Date:  2003

9.  Clinico-pathological and treatment-related factors influencing survival in parotid cancer.

Authors:  A G Renehan; E N Gleave; N J Slevin; M McGurk
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

10.  Salivary duct carcinoma.

Authors:  A Sefik Hosal; Chunyang Fan; Leon Barnes; Eugene N Myers
Journal:  Otolaryngol Head Neck Surg       Date:  2003-12       Impact factor: 5.591

View more
  18 in total

1.  Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.

Authors:  Marlen Haderlein; Claudia Scherl; Sabine Semrau; Sebastian Lettmaier; Markus Hecht; Ramona Erber; Heinrich Iro; Rainer Fietkau; Abbas Agaimy
Journal:  Strahlenther Onkol       Date:  2017-08-21       Impact factor: 3.621

2.  Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.

Authors:  Claudia Scherl; Marlen Haderlein; Abbas Agaimy; Konstantinos Mantsopoulos; Michael Koch; Maximilian Traxdorf; Rainer Fietkau; Philipp Grundtner; Heinrich Iro
Journal:  Strahlenther Onkol       Date:  2019-07-26       Impact factor: 3.621

3.  UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.

Authors:  Kristy A Warner; Alexandra E Oklejas; Alexander T Pearson; Zhaocheng Zhang; Weishing Wu; Vasu Divi; Christie Rodriguez-Ramirez; Rogerio M Castilho; Peter J Polverini; Jacques E Nör
Journal:  Oral Oncol       Date:  2018-10-18       Impact factor: 5.337

4.  Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: A Rare Case.

Authors:  Zaryab Umar; Usman Ilyas; Mohsen S Alshamam; Allison Foster; Rubal Bhangal; Nazaakat Ahmed; Zarwa Idrees
Journal:  Cureus       Date:  2022-05-26

5.  Frequency and imaging features of the adjacent osseous changes of salivary gland carcinomas in the head and neck region.

Authors:  Daisuke Horiuchi; Taro Shimono; Hiroyuki Tatekawa; Taro Tsukamoto; Hirotaka Takita; Masahiro Okazaki; Yukio Miki
Journal:  Neuroradiology       Date:  2022-05-07       Impact factor: 2.995

6.  Distant metastasis of salivary gland cancer: Incidence, management, and outcomes.

Authors:  Ximena Mimica; Marlena McGill; Ashley Hay; Daniella Karassawa Zanoni; Jatin P Shah; Richard J Wong; Alan Ho; Marc A Cohen; Snehal G Patel; Ian Ganly
Journal:  Cancer       Date:  2020-02-25       Impact factor: 6.860

7.  Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis.

Authors:  Boban M Erovic; Manish D Shah; Guillem Bruch; Meredith Johnston; U Johnston; John Kim; Brian O'Sullivan; Bayardo Perez-Ordonez; Ilan Weinreb; Eshetu G Atenafu; John R de Almeida; Patrick J Gullane; Dale Brown; Ralph W Gilbert; Jonathan C Irish; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-10-29

8.  Cytokeratin immunoprofile of primary and metastatic adenoid cystic carcinoma of salivary glands: a report of two cases.

Authors:  Cibele Pidorodeski Nagano; Cláudia Malheiros Coutinho-Camillo; Clovis Antônio Pinto; Fernando Augusto Soares; Filipa Santos; Isabel Fonseca; Silvia Vanessa Lourenço
Journal:  Autops Case Rep       Date:  2016-12-30

9.  Patterns of treatment failure in salivary gland cancers.

Authors:  Mateusz Szewczyk; Paweł Golusiński; Jakub Pazdrowski; Piotr Pieńkowski; Sławomir Marszałek; Jacek Sygut; Wojciech Golusiński
Journal:  Rep Pract Oncol Radiother       Date:  2018-06-23

10.  Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature.

Authors:  Yongfei You; Panpan Wang; Xi Wan; Liping Xu; Yi Gong; Weihua Zhang
Journal:  Onco Targets Ther       Date:  2021-05-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.